Therapeutic peptide delivery via aptamer-displaying, disulfide-linked peptide amphiphile micelles-Reference-Cited by-同舟云学术

Therapeutic peptide delivery via aptamer-displaying, disulfide-linked peptide amphiphile micelles

Published:2020 Issue:1 Volume:5 Page:269-283
ISSN:2058-9689
Container-title:Molecular Systems Design & Engineering
language:en
Short-container-title:Mol. Syst. Des. Eng.

Author:

Smith Josiah D.¹²³⁴⁵,Cardwell Leah N.⁶³⁴⁵,Porciani David⁶³⁴⁵⁷,Nolla Andrea¹²³⁴⁵,Cornelison Brenna T.¹²³⁴⁵,Schulte Megan C.¹²³⁴⁵,Gallazzi Fabio⁸³⁴⁵⁹,Burke Donald H.¹²³⁴⁵,Daniels Mark A.⁶³⁴⁵¹⁰,Ulery Bret D.¹²³⁴⁵^ORCID

Affiliation:

1. Department of Biomedical

2. Biological, and Chemical Engineering

3. University of Missouri

4. Columbia

5. USA

6. Department of Molecular Microbiology and Immunology

7. Bond Life Science Center

8. Molecular Interactions Core

9. Department of Chemistry

10. Department of Surgery

Abstract

Peptide amphiphile micelles (PAMs) are a powerful platform technology for improving the delivery of therapeutic and prophylactic peptides.

Funder

University of Missouri

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,Industrial and Manufacturing Engineering,Process Chemistry and Technology,Energy Engineering and Power Technology,Biomedical Engineering,Chemical Engineering (miscellaneous),Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2020/ME/C9ME00092E

Reference64 articles.

1. SEER Cancer Statistics Review, 1975-2016 , ed. N. Howlader , A. M. Noone , M. Krapcho , D. Miller , A. Brest , M. Yu , J. Ruhl , Z. Tatalovich , A. Mariotto , D. R. Lewis , H. S. Chen , E. J. Feuer and K. A. Cronin , National Cancer Institute , Bethesda, MD , https://seer.cancer.gov/csr/1975_2016/, based on November 2018 SEER data submission, posted to the SEER web site, April 2019

2. Relapsed and refractory aggressive NHL: Time for a change

3. American Cancer Society , Cancer Facts & Figures 2019 , American Cancer Society , Atlanta, GA , 2019

4. Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy

5. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology Advances in the Detection and Treatment of Lymphoid Malignancies;International Journal of Molecular Sciences;2024-08-26

2. Smart nanoparticles for cancer therapy;Signal Transduction and Targeted Therapy;2023-11-03

3. Particle carriers for controlled release of peptides;Journal of Controlled Release;2023-08

4. Nanocarrier system: An emerging strategy for bioactive peptide delivery;Frontiers in Nutrition;2022-12-05

5. Cancer immunomodulation using bispecific aptamers;Molecular Therapy - Nucleic Acids;2022-03